Search research articles
Contact Us
Filters
Showing results (111-120 of 159) with videos related to
Page
of 16
Sort By:
Journal of Psychopharmacology (Oxford, England)
|
March 31, 2009
Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans
F Klumpers, J M van Gerven, E P M Prinssen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma
J P van Meerbeeck, P Baas, C Debruyne, et al.
Psychopharmacology
|
December 3, 2023
Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction
C M B Kwee, F E van der Flier, P Duits, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1996
Radiation pneumonitis imaged with indium-111-pentetreotide
R A Valdés Olmos, N van Zandwijk, L J Boersma, et al.
British Journal of Cancer
|
February 9, 2006
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study
P Baas, J S A Belderbos, S Senan, et al.
Frontiers in Psychiatry
|
June 9, 2022
Stable Anxiety and Depression Trajectories in Late Adolescence for Oral Contraceptive Users
Anne Marieke Doornweerd, Susan Branje, Stefanie A Nelemans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 13, 1999
Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma
J C Theuws, S L Kwa, A C Wagenaar, et al.
Cancer
|
June 22, 1999
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
J P van Meerbeeck, P Baas, C Debruyne, et al.
Depression and Anxiety
|
February 24, 2015
Updated meta-analysis of classical fear conditioning in the anxiety disorders
Puck Duits, Danielle C Cath, Shmuel Lissek, et al.
British Journal of Clinical Pharmacology
|
July 18, 2006
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients
M Joerger, A D R Huitema, H J G D van den Bongard, et al.
Page
of 16
Search research articles
Search
Showing results (111-120 of 159) with videos related to
Sort By:
Page
of 16
Journal of Psychopharmacology (Oxford, England)
|
March 31, 2009
Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans
F Klumpers, J M van Gerven, E P M Prinssen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma
J P van Meerbeeck, P Baas, C Debruyne, et al.
Psychopharmacology
|
December 3, 2023
Effects of cannabidiol on fear conditioning in anxiety disorders: decreased threat expectation during retention, but no enhanced fear re-extinction
C M B Kwee, F E van der Flier, P Duits, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 1, 1996
Radiation pneumonitis imaged with indium-111-pentetreotide
R A Valdés Olmos, N van Zandwijk, L J Boersma, et al.
British Journal of Cancer
|
February 9, 2006
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study
P Baas, J S A Belderbos, S Senan, et al.
Frontiers in Psychiatry
|
June 9, 2022
Stable Anxiety and Depression Trajectories in Late Adolescence for Oral Contraceptive Users
Anne Marieke Doornweerd, Susan Branje, Stefanie A Nelemans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
March 13, 1999
Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma
J C Theuws, S L Kwa, A C Wagenaar, et al.
Cancer
|
June 22, 1999
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
J P van Meerbeeck, P Baas, C Debruyne, et al.
Depression and Anxiety
|
February 24, 2015
Updated meta-analysis of classical fear conditioning in the anxiety disorders
Puck Duits, Danielle C Cath, Shmuel Lissek, et al.
British Journal of Clinical Pharmacology
|
July 18, 2006
Determinants of the elimination of methotrexate and 7-hydroxy-methotrexate following high-dose infusional therapy to cancer patients
M Joerger, A D R Huitema, H J G D van den Bongard, et al.
Page
of 16